CompletedNot applicableNCT02890979
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease
Studying High-grade dysplasia in patients with Barrett esophagus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- OHSU Knight Cancer Institute
- Principal Investigator
- James DolanOHSU Knight Cancer Institute
- Intervention
- Cytology Specimen Collection Procedure(other)
- Enrollment
- 11 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2017
Study locations (1)
- OHSU Knight Cancer Institute, Portland, Oregon, United States
Collaborators
Oregon Health and Science University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02890979 on ClinicalTrials.gov